Swiss reproductive health company raises CHF 60 million

Geneva, Switzerland-based ObsEva SA has raised CHF 60 million (€54.87 million) in a Series B financing round to advance its portfolio of products that treat reproductive problems in women ranging from preterm labour to endometriosis.